ANBT
BIO icon

American National Bank & Trust’s Bio-Rad Laboratories Class A BIO Stock Holding History

American National Bank & Trust’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-7
Closed -$3.35K – 579
2023
Q1 		$3.35K Buy
+7
New +$3.28K ﹤0.01% 459

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

American National Bank & Trust's BIO Position: Q2 2023 in Review

American National Bank & Trust sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2023, closing a stake of 7 shares — an estimated $3.35K sold.

American National Bank & Trust first reported a position in BIO in Q1 2023 and held it in 1 quarter. The position peaked at $3.35K in Q1 2023. 469 funds tracked by Wall St. Rank hold BIO as of Q2 2023.

  • American National Bank & Trust reported no remaining Bio-Rad Laboratories Class A position as of Q2 2023 after selling out during the quarter.
  • American National Bank & Trust sold 7 Bio-Rad Laboratories Class A shares in Q2 2023, an estimated $3.35K.
  • American National Bank & Trust first reported a position in Bio-Rad Laboratories Class A in Q1 2023 and held it in 1 quarter.
  • American National Bank & Trust's Bio-Rad Laboratories Class A position peaked at $3.35K in Q1 2023.
  • 469 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2023.

Based on American National Bank & Trust's 13F filing for Q2 2023, filed 12 Jul 2023.